Brain Damage, Chronic: Clinical Trials

53 trials for Brain Damage, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed. 53 Phase 2, 16 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 253Completed 53
Phase 116Completed 16
Phase 33Completed 3

Follow Brain Damage, Chronic: new trials by email Literature Review of Brain Damage, Chronic trials Research Report on Brain Damage, Chronic

Trials (filtered) newest first · largest first

All 53 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study
Metformin - Cerebral Palsy
Phase 2CompletedHolland Bloorview Kids Rehabilitation Hospital32023-11-142026-03-02
Therapeutic Photobiomodulation and Tretament of Spasticity
Photobiomodulation, Institution's Standard Physiotherapy, Photobiomodulation Placebo - Muscle Spasticity, Cerebral Palsy
Phase 2 / Phase 3CompletedUniversity of Nove de Julho122023-08-152026-05-01
ADX-629 Therapy for Sjogren-Larsson Syndrome
ADX-629 - Sjogren-Larsson Syndrome
Phase 1 / Phase 2CompletedUniversity of Nebraska82023-01-022026-05-05
A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy
UDI-001 - Cerebral Palsy, Periventricular Leukomalacia
Phase 1 / Phase 2CompletedRohto Pharmaceutical Co., Ltd.62021-06-022025-04-06
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-01-15
A Study of UCB and MSCs in Children With CP: ACCeNT-CP
Infusion of allogeneic umbilical cord blood, Infusion of MSCs - Cerebral Palsy
Phase 1 / Phase 2CompletedJoanne Kurtzberg, MD912018-04-102021-08-19
A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness
Zolpidem Tartrate Tablets - Disorder of Consciousness
Phase 2CompletedXijing Hospital362017-12-012022-05-31
Hyperbaric Oxygen for Traumatic and Non-traumatic Brain Injury
Hyperbaric Oxygen, Minimal pressure air - Brain Injury, Chronic
Phase 2CompletedLindell Weaver492017-09-062022-08-04
Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
Intranasal auto-M2-BFs - Organic Brain Syndrome, Nonpsychotic, Neurocognitive Disorders
Phase 1 / Phase 2CompletedRussian Academy of Medical Sciences302016-03-012021-02-18
Calcium Channel Blockers Compared to Magnesium Sulfate in Fetal Cerebral Blood Flow
Magesium sulphate, Nifedipine, Doppler on fetal middle cerebral artery - Preterm Labor, Cerebral Palsy
Phase 2 / Phase 3CompletedKasr El Aini Hospital1302015-12-012017-11-17
Outcomes of Stem Cells for Cerebral Palsy
Autologous Bone Marrow Mononuclear Cells - Cerebral Palsy
Phase 2CompletedVinmec Healthcare System302015-11-052018-05-07
Mechanism of Allogeneic UCB Therapy in Cerebral Palsy
allogeneic cord blood transplantation - Cerebral Palsy, Child Development
Phase 1 / Phase 2CompletedBundang CHA Hospital902015-07-292020-11-04
Tau Imaging of Chronic Traumatic Encephalopathy
[F18]-T807, [F18]-Florbetapir, MRI/MRS - Chronic Traumatic Encephalopathy
Phase 2CompletedBrigham and Women's Hospital302015-01-012018-05-17
The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)
Neurorehabilitation therapy with cast, Neurorehabilitation therapy with splint, Neurorehabilitation bimanual - Hemiparesis, Cerebral Palsy
Phase 1 / Phase 2CompletedVirginia Polytechnic Institute and State University582015-01-012022-03-11
tDCS on Precuneus in MCS: Repeated Stimulations
transcranial direct current stimulation - Patients in Minimally Conscious State After a Severe Brain Injury
Phase 2CompletedHangzhou Normal University332014-12-012016-03-08
Erythropoietin Therapy for Children With Cerebral Palsy
Erythropoietin, Placebo erythropoietin - Cerebral Palsy
Phase 2CompletedBundang CHA Hospital112014-09-012017-10-12
Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
Xeomin, Botox® - Cerebral Palsy, Spastic Paraplegia and Hemiparesis
Phase 2CompletedMerz Pharmaceuticals GmbH642014-07-012017-01-26
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
florbetapir F 18, Flortaucipir F18 - Chronic Traumatic Encephalopathy
Phase 2CompletedAvid Radiopharmaceuticals412014-06-012020-09-07
Enhancing Motor Plasticity After Perinatal Stroke Using tDCS
Interventional TDCS, Sham TDCS - Perinatal Stroke, Cerebral Palsy
Phase 2CompletedUniversity of Calgary232014-05-012015-05-28
Outcomes of Stem Cells for Cerebral Palsy
Autologous Bone Marrow Mononuclear Cells - Cerebral Palsy
Phase 2CompletedVinmec Healthcare System402014-04-012015-10-16

Showing 20 of 53. Sign in to see all of them.

Narrower conditions

Cerebral Palsy (45)  ·  Brain Injuries, Traumatic (4)  ·  Muscle Spasticity (4)  ·  Chronic Traumatic Encephalopathy (3)  ·  Consciousness Disorders (3)  ·  Paresis (3)  ·  Persistent Vegetative State (3)  ·  Stroke (3)  ·  Brain Injuries (2)  ·  Brain Injury, Chronic (2)  ·  Hypoxia-Ischemia, Brain (2)  ·  Intracranial Hemorrhages (2)  ·  Leukomalacia, Periventricular (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Arthrogryposis (1)

Broader conditions

Brain Diseases (53)  ·  Central Nervous System Diseases (53)  ·  Nervous System Diseases (53)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Signs and Symptoms (17)  ·  Neurologic Manifestations (15)  ·  Wounds and Injuries (11)  ·  Craniocerebral Trauma (10)  ·  Trauma, Nervous System (10)  ·  Mental Disorders (9)  ·  Pathologic Processes (9)  ·  Brain Injuries (8)  ·  Cardiovascular Diseases (7)  ·  Cerebrovascular Disorders (7)

Interventions

Botulinum Toxins, Type A (3)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (2)  ·  Acupuncture Therapy (2)  ·  Baclofen (2)  ·  Hyperbaric Oxygenation (2)  ·  Stem Cell Transplantation (2)  ·  Transcranial Direct Current Stimulation (2)  ·  florbetapir (2)  ·  incobotulinumtoxinA (2)  ·  ADX-629 (1)  ·  Botulinum Toxins (1)  ·  Cell Count (1)  ·  Cetuximab (1)  ·  Constraint Induced Movement Therapy (1)  ·  Diffusion Tensor Imaging (1)

Sponsors

Bundang CHA Hospital (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Holland Bloorview Kids Rehabilitation Hospital (2)  ·  Joanne Kurtzberg, MD (2)  ·  University of Oklahoma (2)  ·  University of Southern California (2)  ·  Vinmec Healthcare System (2)  ·  Virginia Polytechnic Institute and State University (2)  ·  Agency for Healthcare Research and Quality (AHRQ) (1)  ·  Avid Radiopharmaceuticals (1)  ·  Brigham and Women's Hospital (1)  ·  Children's Hospital Los Angeles (1)  ·  Eli Lilly and Company (1)  ·  Hangzhou Normal University (1)  ·  Hanyang University Seoul Hospital (1)

Countries

United States (26)  ·  Canada (3)  ·  South Korea (3)  ·  Vietnam (3)  ·  Belgium (2)  ·  China (2)  ·  Egypt (2)  ·  Russia (2)  ·  Brazil (1)  ·  France (1)  ·  Hong Kong (1)  ·  Iran (1)  ·  Japan (1)  ·  Norway (1)  ·  Switzerland (1)

Top investigators

Charles S Cox, MD (2)  ·  Darcy Fehlings, MD, MSc (2)  ·  Joanne Kurtzberg, MD (2)  ·  Liem T Nguyen, MD., PhD. (2)  ·  Minyoung Kim, M.D., Ph.D. (2)  ·  Adam Kirton, MD, MSc (1)  ·  Ahmed M Kamel, M.D. (1)  ·  Alexander A Ostanin, MD, PhD (1)  ·  Ali Reza Zali, MD (1)  ·  Ariane Zoll (1)  ·  Burris Duncan (1)  ·  Burris Duncan, M.D. (1)  ·  Diane L Damiano, Ph.D. (1)

Results publications

PMID 38114596, PMID 28403842, PMID 28688787, PMID 18065878, PMID 18676556, PMID 18990048, PMID 19811515, PMID 22071153, PMID 22541308, PMID 22747635, PMID 22776958, PMID 23106988, PMID 24607242, PMID 24969309, PMID 25157725, PMID 25534356, PMID 25863661, PMID 27187300, PMID 27927938, PMID 28109298, PMID 28867665, PMID 29080265, PMID 30107811, PMID 30782701, PMID 30969506, PMID 31438885, PMID 34649982, PMID 35811372, PMID 36477478, PMID 37555886, PMID 38087394, PMID 905874

NIH funding

P50AT000008 (1), R21AR051564 (1), R21HD054697 (1)